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Summary
To assess whether Smad signaling affects skin devel-
opment, we generated transgenic mice in which a
Smad antagonist, Smad7, was induced in keratino-
cytes, including epidermal stem cells. Smad7 trans-
gene induction perturbed hair follicle morphogenesis
and differentiation, but accelerated sebaceous gland
morphogenesis. Further analysis revealed that inde-
pendent of its role in anti-Smad signaling, Smad7
bound b-catenin and induced b-catenin degradation
by recruiting an E3 ligase, Smurf2, to the Smad7/b-cat-
enin complex. Consequently, Wnt/b-catenin signaling
was suppressed inSmad7 transgenic hair follicles. Co-
expression of the Smurf2 andSmad7 transgenes exac-
erbated Smad7-induced abnormalities in hair follicles
andsebaceousglands.Conversely,whenendogenous
Smad7 was knocked down, keratinocytes exhibited
increased b-catenin protein and enhancedWnt signal-
ing. Our data reveal amechanism for Smad7 in antago-
nizing Wnt/b-catenin signaling, thereby shifting the
skin differentiation program from forming hair follicles
to sebaceous glands.
Introduction
Murine hair follicle morphogenesis starts at an embry-
onic stage and proceeds through the typical eight
stages (Philpott and Paus, 1998). At approximately em-
bryonic day 14.5 (E14.5), certain epidermal stem cells
that reside in the basal layer of the epidermis begin to
designate their fate toward hair follicle morphogenesis.
During hair follicle development, some stem cells mi-
grate downward along growing hair germ to form hair
progenitor cells (matrix cells) in the hair bulb. The hair
progenitor cells will further differentiate into the outer
root sheath (ORS), the inner root sheath (IRS), and the
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Chongqing 400037, China.hair shaft. As hair follicle morphogenesis is completed
perinatally, sebaceous glands begin to develop from
cells residing in a bulge area at the upper portion of
the hair follicle. Postnatal hair follicles cycle through
phases of growth (anagen), regression (catagen), and
rest (telogen) during which sebaceous glands alter their
size proportionally. The hair follicle bulge is more prom-
inent postnatally and is a niche housing multipotent epi-
dermal stem cells, which are responsible for the self-re-
newal of hair follicle cells, sebaceous gland cells, and
postinjury interfollicular epidermal cells (Fuchs et al.,
2004; Watt, 1998; Lavker et al., 2003; Levy et al., 2005).
Hair follicle morphogenesis is tightly controlled by a vari-
ety of signal transduction pathways. For instance, Wnt
signaling is essential for the initiation of hair follicle
development (Andl et al., 2002; Huelsken et al., 2001;
Gat et al., 1998), whereas hedgehog signaling is required
for the down growth of the hair follicle and for sebaceous
gland development (St Jacques et al., 1998; Chiang
et al., 1999; Altaba, 1999; Allen et al., 2003; Mill et al.,
2003).
Recent studies have shown that expression of Smads
and certain Smad target genes is preferentially enriched
in the epidermal stem cell population (Tumbar et al.,
2004; Morris et al., 2004). It is unknown whether Smads
directly affect or interact with other signal transduction
pathways to regulate epidermal stem cell maintenance
and function. To ablate Smad signaling in keratinocytes,
we have previously generated transgenic mice in which
a Smad antagonist, Smad7, is targeted by using the ker-
atin 5 (K5) promoter (He et al., 2002). It has been reported
that Smad7 blocks Smad signaling by inhibiting Smad
phosphorylation and by recruiting a Smad ubiquitina-
tion-related factor (Smurf)2 to degrade the type I recep-
tors of transforming growth factor b (TGFb) and/or
Smads (Massague et al., 2005). Smad7 is often overex-
pressed under pathological conditions, e.g., in intrinsi-
cally aged and photoaged human skin (Quan et al.,
2002) and during skin carcinogenesis (He et al., 2001).
We have shown that Smad7 transgene expression in
keratinocytes inhibits Smad signaling from TGFb/activin
and bone morphogenetic protein (BMP), which results
in multiple developmental defects in stratified epithelia,
including decreased hair follicle size (He et al., 2002).
These mice die perinatally due to epithelial hyperkerato-
sis in the upper digestive tract and severe thymic atro-
phy (He et al., 2002). To further examine the role of
Smad7 overexpression at stages critical for stem cell
fate decision and differentiation as well as in postnatal
hair cycling, in the present study we generated trans-
genic mice, in which Smad7 transgene expression can
be temporally induced in keratinocytes, including epi-
dermal stem cells. The ability to control transgene
expression at a pathologically relevant level and in an
acute or a sustained manner further facilitated analysis
of the underlying molecular mechanisms. Our analyses
revealed a direct interaction between Smad7 and the
Wnt/b-catenin pathway via recruitment of Smurf2 for
b-catenin degradation, which affects hair follicle and
sebaceous gland morphogenesis.
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Smad7 Transgene Induction Perturbed Embryonic
and Postnatal Hair Follicle Morphogenesis
We generated gene-switch-Smad7 mice by using the K5
promoter, in which Smad7 transgene expression can be
induced by RU486 in the epidermis and hair follicles
(Figure S1; see the Supplemental Data available with
this article online). This inducible system consists of a
transactivator line (GLp65) (Lu et al., 2004) and a target
line (tata.Smad7). In general, Smad7 transgene expres-
sion levels were RU486 dose dependent and correlated
with phenotype severity. The data presented here were
from the doses of RU486 that induced Smad7 expres-
sion levels similar to those when endogenous Smad7
is overexpressed, e.g., in aged skin (Quan et al., 2002)
and in cancer lesions (He et al., 2001).
We induced Smad7 transgene expression in embry-
onic skin, beginning on E10.5, when a single epithelial
layer begins transitioning into the stratified epidermis,
or on E14.5, when hair follicle development is initiated.
Skin samples were excised at birth (day one postpar-
tum, P1) after daily RU486 treatments to verify sustained
Smad7 transgene induction. Acute Smad7 transgene
induction was assessed by topical RU486 application
(20 mg/mouse) to the skin of P6 mice for 12 hr. Quantita-
tive RT-PCR revealed anw4-fold elevation in Smad7 ex-
pression in bigenic skin with either acute (12 hr, P6) or
sustained (E14.5–P1) transgene induction compared to
endogenous Smad7 expression levels in monogenic
control skin (Figure 1A). Western analysis shows that
the difference in Smad7 protein levels between Smad7
transgenic and control skin was greater than that in
Smad7 mRNA levels (Figure 1B versus Figure 1A), which
is likely a consequence of Smad7 protein accumulation,
as Smad7 has a relatively long half-life (Liu et al., 2006).
Consistently, the level of Smad7 protein upon sustained
Smad7 transgene induction was higher than with acute
Smad7 transgene induction (Figure 1B). In situ hybrid-
ization for Smad7 mRNA was performed 12 hr after the
transgene was induced. In E15.5 control skin, endoge-
nous Smad7 was detected in the epidermis, stromal
cells, and the hair follicle placode, which is the first stage
(Stage 1) of hair follicle development (Figure 1C). In
E15.5 bigenic skin, the intensity of Smad7 staining had
increased in all layers of the epidermis and was the
strongest in hair follicle placodes (Figure 1C). In control
P6 skin, endogenous Smad7 was detected primarily in
the ORS of hair follicles (Figure 1D). At this stage,
Smad7 was induced primarily in the epidermal basal
layer and the ORS of hair follicles (Figure 1D).
When the Smad7 transgene was constitutively in-
duced beginning either on E10.5 or on E14.5, hair follicle
morphogenesis was delayed and hair follicle differentia-
tion was perturbed in bigenic skin compared to control
skin (Figure S2). In adults, we induced Smad7 transgene
expression during the telogen-to-anagen transition of
the hair follicles. The dorsal skin of bigenic and mono-
genic control mice were shaved on postnatal day 52
(P52), when the hair follicles enter into a long period of
the telogen phase (Paus, 1998). A depilatory cream, Nair,
was applied to the shaved skin to reinitiate the anagen
phase (Paus et al., 1990). The depilated skin was then
topically treated with 20 mg RU486 three times/weekfor 2 weeks. The skin samples at different time points
were collected from the RU486-treated area by 3 mm
punch biopsy. Histological analysis showed that P52
hair follicles in both bigenic and control mice were at
the telogen phase (Figure 2A). On P58 (i.e., 6 days after
Smad7 transgene induction), hair follicles in control
mice grew downward and, in some areas, reached to
the upper part of the subcutaneous layer of the skin
(Figure 2A). In contrast, Smad7 skin exhibited rapid
growth of sebaceous glands without hair follicle down
growth (Figure 2A). Hair follicles in control P64 skin
showed well-differentiated and mature anagen mor-
phology, and most of them developed into the deep
subcutaneous fat (Figure 2A). In contrast, hair follicles
in P64 bigenic skin (i.e., 12 days after Smad7 transgene
induction) grew barely below enlarged sebaceous
glands (Figure 2A). Epidermal hyperplasia was also
prominent in Smad7 transgenic skin (Figure 2A). When
RU486 application was withdrawn on P66 to turn off
Smad7 transgene expression, hair follicle regeneration
gradually recovered (not shown). In contrast, continu-
ous Smad7 transgene induction resulted in the blockade
of hair follicle differentiation similar to that shown in
Figure S2 (not shown), and eventually the hair follicles
degenerated to cysts with hypertrophic sebaceous
glands (Figure 2B). The epidermis was no longer hyper-
plastic, but was thinner than control epidermis (Fig-
ure 2B). At this stage, the skin became hairless in the
Figure 1. Smad7 Transgene Induction
(A) qRT-PCR showed Smad7 transgene induction 12 hr after a single
RU486 (RU) application to P6 skin or daily injection of RU to pregnant
females from gestation day 14.5 (E14.5) to P1. *, p < 0.01.
(B) Western analysis revealed increased Smad7 protein upon acute
(RU 12h) and sustained (RU E14.5-P1) RU486 treatment.
(C and D) In situ hybridization with an antisense probe specific for
Smad7 on (C) E15.5 and (D) P6 skin 12 hr after RU486 treatment.
HF, hair follicle. The bar in the first panel of (C) represents 50 mm
for both micrographs. The bar in each panel of (D) represents 50 mm.
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303Figure 2. Smad7 Induction Perturbed Hair
Follicle Regeneration, but Accelerated Seba-
ceous Gland Morphogenesis
(A–E) Control (monogenic or wild-type) and
gene-switch-Smad7 skin (Smad7) were
treated with RU486 as indicated. (A) Smad7
transgene induction during the telogen-to-
anagen transition perturbed hair follicle re-
generation, but accelerated sebaceous gland
regeneration. The bar in the first panel repre-
sents 75 mm for micrographs in (A). (B) Sus-
tained Smad7 transgene expression for 7
months resulted in degenerated hair follicles,
which formed cysts (c). Black arrows point
to naked dermal papillae. Red arrows point
to hypertrophic sebaceous glands. The left
panel is from a control mouse skin with telo-
gen follicles. The bar in the first panel repre-
sents 100 mm for micrographs. (C) Immuno-
fluorescence with an antibody against
adipophilin (green). The counterstain (red) is
K14. Representative sebocyte clusters and
sebaceous glands are pointed out by white
arrows in control skin and yellow arrows in
Smad7 skin. The bar in the first panel repre-
sents 75 mm for all micrographs. (D) qRT-
PCR of Ihh expression in control and Smad7
transgenic skin treated with RU486 acutely
(12h) or chronically (10d). *, p < 0.01. (E)
Immunohistochemistry with an antibody
against Ihh. Red arrows point to sebaceous
glands in P7 control and Smad7 transgenic
skin, both of which had been treated with
RU486 for 6 days beginning on P1. Hematox-
ylin was used as a counterstain. The bar in the
first panel of (E) represents 40 mm for both
sections.focal area with sustained Smad7 transgene induction
(not shown).
Smad7 Overexpression Resulted in Premature
Sebaceous Gland Development
When we activated Smad7 transgene expression in skin
beginning on E14.5, rudimentary sebaceous glands
formed in association with the upper portion of P1 hair
follicles in bigenic skin. These glands stained positively
for adipophilin, an early sebaceous gland differentiation
marker (Heid et al., 1998), whereas no adipophilin-posi-
tive cells were detected in control skin (not shown). To
determine if accelerated sebaceous gland development
in Smad7 transgenic skin represents a direct effect of
Smad7 overexpression, we examined the time course
of sebaceous gland formation after Smad7 transgene
induction. RU486 (5 mg/mouse) was topically applied
daily to the dorsal skin of control and bigenic neonates,
beginning on P1. On P3, control skin did not exhibit
adipophilin-positive cells, whereas rudimentary glands
appeared in Smad7 hair follicles (Figure 2C). On P5, after
4 days of RU486 treatment, control skin showed more
adipophilin-positive cells, but every bigenic hair follicle
had developed sebaceous glands (Figure 2C). On P7,rudimentary sebaceous glands were forming in asso-
ciation with most of the hair follicles in control skin,
whereas the sebaceous glands in bigenic follicles be-
came further enlarged after 6 days of Smad7 induction
(Figure 2C). We examined expression levels of sonic
hedgehog (Shh) and indian hedgehog (Ihh), two mole-
cules required for sebaceous gland development (Allen
et al., 2003; Niemann et al., 2003). In situ hybridization
showed Shh expression in proliferative hair matrix cells
of Smad7 hair follicles with a similar intensity to those
in control hair follicles (not shown). Ihh expression levels
were not significantly different from control levels at
12 hr after Smad7 induction, but they mildly increased
after 10 days of Smad7 transgene induction (Figure 2D).
Elevated Ihh protein was localized in the sebaceous
glands of transgenic Smad7 skin (Figure 2E).
Smad7 Transgene Induction Partially
Blocked Smad Signaling
To determine whether the current Smad7 transgene
level is sufficient to block Smad signaling, we examined
phospho-Smad2 (pSmad2) and pSmad1/5/8, which rep-
resent activation of TGFb/activin and BMP, respectively,
in the skin. In comparison with control skin, nuclear
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304Figure 3. Smad7 Transgenic Skin Exhibited
a Reduction in b-Catenin Staining and in b-
Catenin-Mediated Wnt Signaling
(A) Immunohistochemistry of b-catenin on P6
control and Smad7 skin. The areas of the epi-
dermis (Epi) and hair follicles (HF) marked by
black boxes are enlarged to the right of the
main panels. Hematoxylin was used as a
counterstain. The bar represents 75 mm for
both main panels.
(B) Immunofluorescence reveals nuclear
staining for b-catenin in hair germ cells of
E15.5 control, but not Smad7, hair follicles.
Dotted lines denote the epidermal-dermal
boundaries. The bar in the lower panel repre-
sents 50 mm for both sections.
(C) Whole-mount b-gal staining on E15.5
TOPGAL+/Smad72 and TOPGAL+/Smad7+
embryos. The embryos were taken after 5
days of in utero RU486 treatment. No differ-
ence in staining intensity in the bone (yellow,
open arrow) and cartilage (red, open arrow)
was observed between the two genotypes.
Representative areas from both embryos
are enlarged to show positive staining in
pelage hair follicles.
(D) Microscopic appearance of the embry-
onic skin shown in (C). The dotted lines
denote developing hair germs. Note that
while the two Stage 1 (S1) hair follicles in the
TOPGAL+/Smad7+ section did not exhibit
positive b-gal staining, the staining intensity
in bone tissue (red arrows) of the same
section was similar to that in TOPGAL+/
Smad72 bone tissue. The bar in the left panel
represents 100 mm for both sections.
(E) b-gal staining on P6 skin with or with-
out 5 days of Smad7 transgene induction
(TOPGAL+/Smad7+ or TOPGAL+/Smad72,
respectively). The bar in the left panel repre-
sents 150 mm for both sections.pSmad2 staining was reduced in the epidermis and hair
follicles of Smad7 transgene skin, whereas nuclear stain-
ing for pSmad1/5/8 was reduced in the Smad7 epidermis
but not the hair follicles (Figure S3). Additionally, we ex-
amined expression levels of several Smad target genes.
Expression levels of p21 were reduced in Smad7 trans-
genic skin (Figure S4). In contrast, expression of c-myc
and Lef1, two target genes involved in hair follicle/seba-
ceous gland development and differentiation (Arnold
and Watt, 2001; Braun et al., 2003; Qiao et al., 2005),
was not significantly altered in Smad7 transgenic skin
(Figure S4). These results suggest that Smad7 transgene
induction at the current level is insufficient to completely
block Smad signaling in hair follicles.
Smad7 Overexpression Resulted in the
Downregulation of b-Catenin-Mediated Signaling
To explore alternative mechanisms underlying Smad7-
induced hair follicle/sebaceous gland abnormalities,
we examined b-catenin expression and localization.
We induced sustained Smad7 transgene expression be-
ginning on E10.5 and excised the skin on E15.5 and P6.
The b-catenin transcriptional level was not altered after
Smad7 transgene induction (not shown). However, im-
munostaining revealed that the intensity of membranestaining of b-catenin was reduced in Smad7 transgenic
epidermis and hair follicles compared to that in control
skin (Figure 3A). By using conditions that partially de-
stroy the membrane bound b-catenin but increase per-
meability to allow for better detection of nuclear b-cate-
nin (Van Mater et al., 2003), we observed b-catenin in the
nucleus of the germ cells of E15.5 control hair follicles
(Figure 3B) and matrix cells of P6 control follicles (not
shown); however, b-catenin was almost undetectable
in these cell populations in Smad7 transgenic follicles
(Figure 3B).
To determine whether reduced levels of b-catenin
protein affect Wnt signaling, we bred Smad7 bigenic
mice with TOPGAL reporter mice in which lacZ gene
expression is induced by Wnt/b-catenin signaling (Das-
Gupta et al., 2002). Skin samples were taken from E15.5
embryos that had received daily RU486 exposure since
E10.5. Whole-mount b-galactosidase (b-GAL) staining
on E15.5 embryos yielded numerous blue spots with
a well-organized pattern in the trunk skin of TOPGAL+/
Smad72 embryos, highlighting the pelage hair follicles
(Figure 3C). In contrast, the number and intensity of blue
spots were significantly reduced in TOPGAL+/Smad7+
E15.5 embryos (Figure 3C). Tissue sections from the
above-described embryos showed that although Smad7
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305Figure 4. Smad7 Transgene Expression Trig-
gered b-Catenin Degradation
(A) Western analysis of b-catenin in control
and bigenic skin (Smad7) treated with
RU486 either acutely (RU 12h) or chronically
(RU 10d). E-cadherin is a loading control.
(B) Western analysis of b-catenin on cultured
keratinocytes in the absence and presence of
MG132. A K14 antibody was used as a loading
control.
(C) Coimmunoprecipitation of Smad7 and
b-catenin in lysates prepared from cultured
gene-switch-Smad7 keratinocytes in the
presence of MG132. The antibody for Flag,
which recognizes the Flag-Smad7 transgene,
or for b-catenin was used for immunopre-
cipitation, and a mouse IgG was used as
a negative control in immunoprecipitation.
The whole-cell lysate (WCL) from control ker-
atinocytes treated with MG132 was used as a
positive control for Western blotting with an
antibody against b-catenin or Smad7.
(D) Ubiquitin assay for b-catenin protein.
HEK293 T cells were transfected with expres-
sion constructs for His-tagged b-catenin,
Flag-Smurf2, Flag-Smurf2C716S, and Flag-
Smad7, in combinations as indicated. West-
ern analysis was performed to detect ubi-
quitinated b-catenin by using an anti-HA
antibody (upper) and to detect total levels of
b-catenin in cells by using an anti-His anti-
body (bottom).
(E) Western analysis for b-catenin protein. HEK293 T cells were transfected with expression constructs in combinations as indicated. The His-b-
catenin level was detected with an anti-His antibody, and Smurf2 and Smad7 levels were detected with an anti-Flag antibody. A GFP antibody
was used as a loading control since a GFP expression vector was included in all transfection experiments.transgene induction did not block hair follicle initiation,
TOPGAL+/Smad7+ embryonic follicles exhibited little
to no b-GAL staining in the placodes (Figure 3D). When
RU486 was applied daily to neonatal bigenic skin for
5 days, the precortex region of P6 hair follicles in
TOPGAL+/Smad72 control skin stained strongly with
b-GAL (Figure 3E). However, b-GAL staining was dimin-
ished in hair follicles with Smad7 transgene induction
(Figure 3E).
Smad7 Overexpression Triggered
b-Catenin Degradation
We further assessed b-catenin protein levels in control
and transgenic skin. As shown in Figure 4A, b-catenin
protein was significantly reduced in the skin upon acute
(12h) and sustained (10d) Smad7 induction. In contrast,
the amount of E-cadherin, a protein associated with b-
catenin in the adhesion complex, was not altered in
Smad7 transgenic skin (Figure 4A) as when normalized
to the level of K14 protein (not shown). To determine
whether reduced b-catenin protein in Smad7 transgenic
keratinocytes was a result of b-catenin protein degrada-
tion, we examined b-catenin protein levels in cultured
control and transgenic keratinocytes treated with and
without MG132, a ubiquitin proteasome inhibitor. Kera-
tinocytes were treated for 12 hr with 1027 M RU486 to in-
duce Smad7 transgene expression (Smad7 transgenic)
or with vehicle alone (control), and they were then
treated for 4 hr with or without 20 mM MG132. In the
absence of MG132, b-catenin protein was significantly
reduced in Smad7 transgenic keratinocytes compared
to control keratinocytes, but it was recovered uponMG132 treatment (Figure 4B). This result suggests that
Smad7 induces b-catenin degradation via a ubiquitin
proteasome pathway.
We then examined whether Smad7 protein is physi-
cally associated with b-catenin. Immunoprecipitation
with either the Flag antibody, which recognizes the
Flag-Smad7 transgene, or the b-catenin antibody
showed that Smad7 transgenic protein coprecipitated
with b-catenin in the presence of MG132 in cultured ker-
atinocytes (Figure 4C), but that it did not associate with
b-transducin repeat-containing protein (b-TrCP, not
shown), which normally initiates b-catenin degradation
(Latres et al., 1999). We then performed a b-catenin ubiq-
uitination assay to examine whether Smurf2, a ubiquitin
E3 ligase that is recruited by Smad7 (Kavsak et al.,
2000; Izzi and Attisano, 2004), could induce b-catenin
ubiquitination. This assay involved transfection of a
His-tagged b-catenin (His-b-catenin) to a human embry-
onic kidney cell line (HEK293 T cells) with additional ex-
pression vectors, including Flag-tagged Smad7 (Flag-
Smad7), Flag-tagged Smurf2 (Flag-Smurf2), HA-tagged
ubiquitin, and a Smurf2C716A mutant that is catalytically
inactive. Transfected cells were treated with 20 mM
MG132 for 4 hr. His-b-catenin and its ubiquitinated prod-
ucts were immobilized on Ni-NTA beads, eluted under
denaturing conditions, and subjected to Western analy-
ses. An antibody specific for HA-ubiquitin was used to
detect ubiquitinated b-catenin. Ubiquitinated b-catenin
was not detected without the addition of exogenous
ubiquitin (Figure 4D, lane 1), but it was detected upon
addition of ubiquitin to the lysate (Figure 4D, lane 2).
Transfection with Smad7 (Figure 4D, lane 3) mildly
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fection with HA-ubiquitin alone, presumably due to the
low level of endogenous Smurf2 (not shown). Transfec-
tion with Smurf2 (Figure 4D, lane 4) induced a higher level
of b-catenin ubiquitination compared to Smad7 trans-
fection alone, presumably due to a high endogenous
Smad7 level (not shown). Cotransfection with Smurf2
and Smad7 resulted in the highest degree of b-catenin
ubiquitination (Figure 4D, lane 5). Cotransfection of
Smad7 and Smurf2C716A exhibited b-catenin ubiquiti-
nation at a level similar to that of transfection with
Smad7 alone (Figure 4D, lane 6), suggesting that
Smad7-mediated b-catenin ubiquitination requires the
E3 ligase activity of Smurf2. Hence, b-catenin ubiquitina-
tion induced by Smad7 alone or by Smurf2 alone likely
depended on the endogenous levels of each other. To
further assess whether Smad7/Smurf2-induced b-cate-
nin ubiquitination leads to b-catenin degradation, we ex-
aminedb-catenin protein levels 48 hr after transfection of
His-b-catenin to HEK293 T cells with Smad7 and/or
Smurf2. Each of these conditions resulted in reduced
b-catenin levels (Figure 4E). Collectively, these data
suggest that Smurf2 is involved in Smad7-mediated b-
catenin degradation through the ubiquitin proteasome
pathway.
Smurf2-Mediated b-Catenin Degradation
Exacerbated Smad7-Mediated Skin Defects
To determine whether Smad7-mediated b-catenin deg-
radation depends on its role in blocking TGFb/BMP sig-
naling, we examined pSmad2 and pSmad1/5/8 in a
K5.Smad7 transgenic line in which the Smad7 transgene
expression level was only 2-fold higher than that of en-
dogenous Smad7 (Figure 5A); these cells still exhibited
hair follicle defects. This transgenic line was developed
as previously described (He et al., 2002), except that the
founder had a low transgene expression level and thus
survived to adulthood. In K5.Smad7 skin, Smad7 trans-
gene expression was insufficient to reduce pSmad2 and
pSmad1/5/8 (Figure 5B). The numbers of cells positive
for nuclear pSmad2 were 175 6 12/mm epidermis and
115 6 9/hair follicle in control skin, and 190 6 15/mm
epidermis and 109 6 11/hair follicle in Smad7 skin (n =
5, p > 0.05). The numbers of cells positive for nuclear
pSmad1/5/8 were 190 6 13/mm epidermis and 25 6 5/
hair follicle in control skin and 180 6 16/mm epidermis
and 24 6 3/hair follicle in Smad7 skin (n = 5, p > 0.05).
However, when this K5.Smad7 line was bred with
TOPGAL mice, Wnt reporter activity was completely
abolished in the anagen hair follicles of TOPGAL/
K5.Smad7 skin (Figure 5C). Thus, Smad7-induced
b-catenin degradation and the subsequent Wnt signal-
ing blockade appeared to be independent of its role in
blocking TGFb/BMP signaling.
To determine whether Smurf2 expression alone is suf-
ficient to induce skin abnormalities similar to those in
Smad7 transgenic skin, we generated Smurf2 transgenic
mice by using the K5 promoter (K5.Smurf2). K5.Smurf2
skin did not show obvious abnormalities (Figures 6A–
6D) or b-catenin degradation (Figure 6E). Since the level
of endogenous Smad7 is very low in normal skin, we sus-
pected that Smurf2 activation requires a Smad7 level
higher than the endogenous Smad7 level. We bred
K5.Smurf2 mice with the above-described K5.Smad7transgenic line. In neonates, the morphology of
K5.Smurf2 skin was indistinguishable from nontrans-
genic control littermates, i.e., most hair follicles in control
and K5.Smurf2 skin are in Stages 3–5 (Figure 6A). The
majority of K5.Smad7 hair follicles were in Stages 2
and 3 (Figure 6A). However, most hair follicles in mouse
skin coexpressing the Smurf2 and Smad7 transgenes
(Smad7/Smurf2) were in Stages 1 and 2 (Figure 6A).
Staining with adipophilin revealed an absence of sebo-
cytes in P1 control and K5.Smurf2 skin (Figure 6B). In
contrast, a number of sporadic sebocytes were detected
in P1 K5.Smad7 skin, and a greater number of sebocytes
were observed in Smad7/Smurf2 skin (Figure 6B). The
synergistic effect of Smad7 and Smurf2 was more obvi-
ous in adult skin. At P25, the skin of control and
K5.Smurf2 littermates appeared completely normal.
K5.Smad7 littermates began to show patchy hair loss
at this age (Figure 6C), and K5.Smad7/K5.Smurf2 litter-
mates exhibited nearly complete hair loss (Figure 6C).
Figure 5. Low Level of Smad7 Overexpression Did Not Alter Smad
Signaling, but Inhibited Wnt/b-Catenin Signaling
(A) The Smad7 transgene expression level in K5.Smad7 skin as de-
termined by qRT-PCR results (n = 5; *, p < 0.05).
(B) Immunohistochemistry (pSmad2, upper panels) and double im-
munofluorescence (pSmad1/5/8, green, lower panel) show that the
numbers of cells positive for nuclear pSmad2 or pSmad1/5/8 in
P28 skin were comparable between control and K5.Smad7 skin.
Hematoxylin was used as a counterstain for immunohistochemistry.
A K14 antibody was used for counterstain (red) with pSmad1/5/8.
The bar in the top left panel represents 50 mm for both immunohisto-
chemistry panels, and the bar in the lower left panel represents
50 mm for both immunofluorescence panels.
(C) b-gal staining was present on the anagen phase (P30) hair folli-
cles in TOPGAL skin but was abolished in TOPGAL/K5.Smad7 hair
follicles. The bar in the left panel represents 50 mm.
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307Figure 6. Smurf2 Overexpression Exacer-
bated Smad7-Mediated Hair Follicle Abnor-
malities and b-Catenin Degradation
(A) Histology of P1 mouse skin. The bar in the
first panel represents 100 mm for all four sec-
tions. Developmental stages (S) of hair folli-
cles in each section are indicated at the
arrows.
(B) IF with an adipophilin antibody (green) on
P1 mouse skin shows accelerated sebocyte
(arrows) differentiation in K5.Smad7 and
K5.Smad7/K5.Smurf2 transgenic skin. The
counterstain (red) was K14. The bar in the first
panel represents 100 mm for all sections.
(C) Gross appearance of P25 littermates.
(D) Histology of the skin excised from the mice
shown in (C). Both control and K5.Smurf2
(Smurf2) transgenic skin exhibited normal
telogen hair follicles. K5.Smad7 (Smad7)
skin exhibited follicles in anagen (black
arrows), catagen (red arrow), and telogen
(blue arrow) phases. K5.Smad7/K5.Smurf2
(Smad7/Smurf2) skin exhibited degenerated
hair follicles, which formed cysts (green
arrows) and canals (yellow arrow), as well as
enlarged sebaceous glands. The bar in the
first panel represents 200 mm for all sections.
(E) Western analysis of b-catenin, Smad7, and
Smurf2 protein levels in neonatal transgenic
and control skin. A K14 antibody was used
as a loading control. Quantified bars with
standard deviations were averaged from two
samples in each group shown on the Western
blots.
(F) Coimmunoprecipitation of b-catenin,
Smad7, and Smurf2. Lysates were prepared
from cultured keratinocytes treated with
MG132 from mice with the indicated geno-
types. Immunoprecipitatation was performed
with a b-catenin antibody. Western analyses
were performed with an anti-Flag antibody
that recognizes both Smad7 and Smurf2
transgenic proteins. A mouse IgG was used
as a negative control in immunoprecipitation.Histological analysis of skin samples revealed that hair
follicles in control and K5.Smurf2 skin were in the telogen
(resting) phase (Figure 6D). In contrast, K5.Smad7 skin
exhibited aberrant hair follicle cycling, i.e., a mix of ana-
gen, catagen, and telogen follicles appeared in the same
region, and sebaceous glands of similar size among hair
follicles at different phases (Figure 6D). K5.Smad7/
Smurf2 littermates exhibited degenerated hair follicles,
resulting in papillary cysts and canals (Figure 6D). Seba-
ceous glands were more hypertrophic in K5.Smad7/
Smurf2 skin than those in K5.Smad7 skin (Figure 6D).
These data provide in vivo evidence that the effect of
Smurf2 on hair follicle/sebaceous gland morphogenesis
is Smad7 dependent. Correlating with the severity of the
skin phenotypes, levels of b-catenin protein were re-
duced w50% and w80% in K5.Smad7 and K5.Smad7/
K5.Smurf2 skin, respectively (Figure 6E).
To further confirm that Smurf2 was recruited by
Smad7 to the b-catenin complex and therefore induced
b-catenin degradation, we performed immunoprecipita-
tion assays with an antibody against b-catenin, followed
by Western analysis with an antibody against the Flag
tag fused to the Smad7 and the Smurf2 transgenes.
Keratinocytes were isolated from control, K5.Smad7,
K5.Smurf2, and K5.Smad7/K5.Smurf2 skin and treatedwith 20 mM MG132 for 4 hr. The amount of Smad7 that
coprecipitated with b-catenin from lysates of Smad7
transgenic keratinocytes was comparable to the amount
from lysates of Smad7/Smurf2 keratinocytes (Figure 6F).
The Smurf2 protein was coprecipitated with b-catenin in
lysates from Smad7/Smurf2 keratinocytes, but it was
barely detectable in Smurf2 transgenic keratinocytes,
even though these cells contained an amount of Smurf2
protein similar to that in Smad7/Smurf2 transgenic cells
(Figure 6F). This result suggests that Smurf2 did not bind
independently to b-catenin, but that it was recruited by
Smad7 to the b-catenin complex.
Endogenous Smad7 Was Involved in b-Catenin
Degradation and Wnt Signaling Inhibition
In aged skin, which characteristically exhibits reduced
hair follicles and enlarged sebaceous glands, Smad7 is
overexpressed (Quan et al., 2002). Therefore, we as-
sessed whether Smad7 overexpression in aged skin re-
duced b-catenin protein levels. Skin samples with telo-
gen hair follicles from wild-type B6D2 mice (the same
strain as the transgenic skin) at 2 months (‘‘young’’)
and 2 years (‘‘aged’’) of age were examined. The aged
mice exhibited typical aging-related, but not dermatitis-
related, sparse hairs. Histology reveals that, similar to
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b-Catenin Degradation
(A) Histology of 2-month-old (2 mos) and
2-year-old (2 yrs) mouse skin showing in-
creased sizes and numbers of sebaceous
glands and degenerated hair follicles in
aged skin. The bar represents 100 mm for
both sections.
(B) qRT-PCR of Smad7 mRNA in 2 mos and 2
yrs mouse skin. *, p < 0.01.
(C) Western blots with antibodies against b-
catenin and Smad7. A K14 antibody was
used as a loading control.
(D) Smad7 knockdown assay with siRNA spe-
cific for Smad7. The Western blot (left panel)
includes two pairs of mock- and siRNA-trans-
fected wild-type keratinocytes. A K14 anti-
body was used as a loading control. The
intensity of the b-catenin and Smad7 bands
in each corresponding lane was further nor-
malized to K14 (right panel), in which the
b-catenin and Smad7 levels in mock-trans-
fected cells (lanes 1 and 3) were both set arbi-
trarily as 100%.
(E) b-gal staining for cultured TOPGAL hair
follicle cells showing increased b-GAL-posi-
tive cell clusters in Smad7 siRNA-transfected
cells compared to those in the mock-trans-
fected control.the pathological alterations in 7-month-old Smad7
transgenic skin shown in Figure 2B, aged skin, com-
pared to young skin, exhibited numerous enlarged se-
baceous glands and degenerated hair follicles (Fig-
ure 7A). In comparison with young mouse skin, aged
mouse skin exhibited a 6-fold increase in the Smad7
mRNA level (Figure 7B), which was similar to that of
Smad7 transgene expression (Figure 1A). Western anal-
ysis further confirmed the increase of Smad7 protein in
aged skin (Figure 7C) to be at a level similar to that in
Smad7 transgenic protein shown Figure 1B. The level
of b-catenin protein was significantly lower in aged
skin than in young skin (Figure 7C). To further determine
whether endogenous Smad7 is involved in b-catenin
degradation, we transfected wild-type primary mouse
keratinocytes with Smad7 siRNA and examined b-cate-
nin protein levels. Western analysis showed that Smad7
siRNA significantly reduced the endogenous Smad7
level by over 70% (Figure 7D). Conversely, the b-catenin
protein level was increased by w80%–100% in Smad7
siRNA-transfected cells compared to mock-transfected
cells (Figure 7D). These data suggest that endogenous
Smad7 is involved in b-catenin degradation. To assess
whether endogenous Smad7-mediated b-catenin deg-radation affects Wnt signaling, we transfected Smad7
siRNA to hair follicle cells isolated from TOPGAL re-
porter mice. Similar to that seen in vivo (Figure 3E), b-
GAL staining was positive in precortex hair follicle cells
(Figure 7E). In mock-transfected TOPGAL follicle cells,
w20% of the hair follicles contained b-GAL-positive
cells (Figure 7E). In contrast, in Smad7 siRNA-trans-
fected TOPGAL follicle cells,w80% of hair follicles pos-
sessed b-GAL-positive cells (Figure 7E). These data
suggest that endogenous Smad7 inhibits Wnt signaling.
Discussion
Smad7 Induces b-Catenin Degradation Independent
of Its Effect on Blocking TGFb/BMP Signaling
Previously, we have identified a role for Smad7 in block-
ing TGFb/activin and BMP signaling in keratinocytes,
which contributes greatly to epidermal hyperprolifera-
tion and delayed hair follicle development (He et al.,
2002). In the current study, when the Smad7 transgene
was expressed at a level lower than in the previous
study, the hyperproliferative effect was not as severe,
whereas the effect on hair follicle morphogenesis was
just as severe. Consistently, under the current levels of
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hibited or did not inhibit TGFb/BMP signaling, Smad7
still induced b-catenin degradation and Wnt inhibition.
Therefore, Smad7-induced b-catenin degradation ap-
peared to be independent of its effect on inhibiting
TGFb signaling.
Consistent with a previous report (Edlund et al., 2005),
we confirmed a direct association between Smad7 and
b-catenin. We further found that Smad7 recruited Smurf2
to mediate b-catenin ubiquitination and subsequent
degradation. Similar to the manner in which Smurf2 ubiq-
uitinates other substrates (Kavsak et al., 2000; Izzi and
Attisano, 2004; Ogunjimi et al., 2005; Lin et al., 2000;
Zhang et al., 2001), Smurf2 did not directly bind to b-cat-
enin, but it was recruited by Smad7. Once Smurf2 is re-
cruited to the Smad7/b-catenin complex, the E3 ligase
activity of Smurf2 is required for b-catenin ubiquitination
and degradation. This is evidenced by the fact that
the enzyme-deficient Smurf2 mutant did not cooperate
with Smad7 for b-catenin degradation. Our data also
suggest that endogenous Smad7 may use this mecha-
nism to degrade b-catenin, since endogenous Smad7
levels inversely correlated with b-catenin levels between
aged and young skin and Smad7 siRNA-treated kerati-
nocytes exhibited increased b-catenin protein levels.
However, it remains to be determined if once Smad7 ex-
pression reaches the level sufficient to inhibit TGFb/BMP
signaling, it induces additional b-catenin degradation
mechanisms, which are a result of blocking the TGFb/
BMP target genes that regulate either b-catenin stabili-
zation or Wnt signaling. In either case, both the biochem-
ical activity and functions of Smurf2 in keratinocytes
appeared to depend on Smad7 levels, as Smurf2 trans-
genic skin did not exhibit any abnormalities in skin devel-
opment, but exacerbated the abnormalities in Smad7
transgenic skin.
Smad7-Increased b-Catenin Degradation
Contributes to Wnt Signaling Inhibition
in Physiological and Pathological Conditions
Although b-catenin protein is expressed at a high level in
keratinocytes in both interfollicular epidermis and hair
follicles, Wnt signaling activity can only be detected in
certain cell populations of hair follicles (Kobielak et al.,
2003; Lowry et al., 2005; Van Mater et al., 2003), and it
is crucial for development and differentiation of hair
follicles, but not the epidermis (Huelsken et al., 2001).
In the current study, we show that as a result of
Smad7-initiated b-catenin degradation, Wnt/b-catenin
signaling in hair follicles was reduced. The degree of b-
catenin degradation correlated with the severity of hair
follicle defects. Furthermore, the aged mouse skin,
which expressed endogenous Smad7 at a level similar
to that in gene-switch-Smad7 skin, also showed signifi-
cant reduction of b-catenin protein and histopathologi-
cal changes strikingly similar to the skin with sustained
Smad7 transgene induction. Therefore, under a patho-
logical condition, Smad7-mediated b-catenin degrada-
tion contributed, at least in part, to the defect of hair
follicle morphogenesis.
Given the fact that endogenous Smad7 is expressed
at a very low level in keratinocytes (He et al., 2001), we
were surprised to find a marked increase in b-catenin
protein and enhanced Wnt signaling after knockingdown endogenous Smad7 in keratinocytes. Since Wnt
signaling is dominant during hair follicle initiation, en-
dogenous Smad7-mediated b-catenin degradation and
Wnt inhibition should not be sufficient to perturb hair
follicle morphogenesis. However, this may represent a
negative feedback mechanism to prevent de novo hair
follicle formation. Therefore, our study prompts future
studies on the contribution of endogenous Smad7 in
hair follicle homeostasis by keratinocyte-specific Smad7
ablation.
Accelerated Sebaceous Gland Development Induced
by Smad7 Overexpression Represents a Shifted
Balance between b-Catenin/Wnt Signaling
and Hedgehog Signaling
It has been shown that reduced Wnt signaling and/or
enhanced hedgehog signaling stimulates committed
stem cell progenitors to differentiate toward the sebo-
cyte lineage (Labbe et al., 2000; Niemann et al., 2003;
Allen et al., 2003; Takeda et al., 2006). In early stages
of hair follicle development (e.g., embryonic stages), ac-
tivation of both Wnt/b-catenin and hedgehog signaling
is crucial, and a positive regulatory loop between these
two pathways has been suggested (Watt, 2004). Con-
versely, reduced Wnt signaling subsequently results in
reduced hedgehog signaling, which perturbs the devel-
opment of hair follicles and sebaceous glands (Watt,
2004; Kalderon, 2002; Huelsken et al., 2001). The re-
quirement for a proper balance between Wnt/b-catenin
signaling and hedgehog signaling on stem cell fate deci-
sion and differentiation is also evidenced by the normal
hair follicle developmental process, in which sebaceous
gland development in mice does not occur until after
birth, when Wnt/b-catenin signaling begins to decline
and hedgehog signaling continues (Kobielak et al.,
2003; Watt, 2004). In the present study, we observed
that while Wnt signaling was directly reduced in
Smad7 transgenic skin, expression of Shh was still pres-
ent in proliferative hair matrix cells of Smad7 hair folli-
cles (not shown). An upregulation of Ihh was observed
in sebocytes of Smad7 transgenic skin after constitutive
Smad7 transgene induction. This result indicates that
although Ihh is not likely a direct target of Smad7, activa-
tion of hedgehog signaling still occurs, at least in seba-
ceous glands. Therefore, suppression of Wnt/b-catenin
signaling along with relatively intact hedgehog signaling
in Smad7 transgenic keratinocytes appeared to pro-
mote committed stem cell progenitors to differentiate
toward the sebocyte lineage.
In summary, our study identified an alternative b-cate-
nin degradation mechanism mediated by Smad7 and
subsequent Smurf2 recruitment. Our data suggest that
the maintenance of a low Smad7 level in the skin is es-
sential to permit the balanced signaling between Wnt/
b-catenin and hedgehog pathways for normal hair follicle
and sebaceous gland development and regeneration.
Hence, overexpression of Smad7 under a pathological
condition perturbs such a balance. Given the significant
variations of endogenous Smad7 levels in b-catenin-
positive cells during development, a high frequency of
Smad7 overexpression in pathological conditions, and
multiple functions of b-catenin in Wnt signaling and ad-
hesion, our study prompts future investigations regard-
ing the impact of the interaction between Smad7 and
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Experimental Procedures
Generation of Transgenic Mice Overexpressing Smad7
and/or Smurf2
The gene-switch-Smad7 transgenic mice were generated by using
the gene-switch transgenic system as we previously described (Lu
et al., 2004). The activator (GLp65) line was generated previously
(Lu et al., 2004). The target line (tata.Smad7) was generated by
inserting a full-length mouse Smad7 cDNA with a 50 Flag epitope
into a minimal tata promoter with GAL4 binding sites (Lu et al.,
2004). The generation of K5.Smad7 mice was described in our pre-
vious study (He et al., 2002). The offspring showed the same pheno-
types throughout generations. To generate K5.Smurf2 transgenic
mice, the human Smurf2 cDNA with a Flag epitope (Lin et al., 2000)
was inserted into the K5 promoter and microinjected into the pronu-
clei of mouse embryos obtained from ICR female mice mated to
B2D6 male mice. PCR genotyping was performed with primers spe-
cific for a fragment between 468 bp and 950 bp in the full-length
human Smurf2 cDNA (forward: 50-CTCGGTTGTGTTCGTCTTCT-30,
reverse: 50-TGGTAGGTCTGGAGGAGTAT-30).
In Situ Hybridization
In situ hybridization for Smad7 and Lef1 was performed by using di-
goxigenin-11-dUTP-labeled probes as we have previously de-
scribed (He et al., 2001; Qiao et al., 2005). The cDNA fragment was
first amplified by reverse transcriptase PCR with primers specific
for a mouse Smad7 (accession number: NM_008543, forward: 50-
GCTCACGCACTCGGTGCTCA-30, reverse: 50-CCAGGCTCCAGAAG
AAGTTG-30) cDNA sequence and then subcloned into the pGEM-T
easy vector (Promega, Madison, WI). The plasmid was further linear-
ized and purified to create templates for the synthesis of in situ
hybridization probes.
Histology, Immunofluorescence, and Immunohistochemistry
Skin samples were fixed in 10% neutral-buffered formalin, embed-
ded in paraffin, sectioned, and stained with hematoxylin and eosin
(H&E). Immunofluorescence (IF) or immunohistochemistry (IHC)
was performed on OCT-embedded frozen sections or paraffin-
embedded sections as previously described (Wang et al., 1997).
The antibodies used included: K14 (CRP, Denver, PA), AE15 and
AE13 (gifts from Dr. Tung-Tien Sun), adipophilin (Fitzgerald, Con-
cord, MA), b-catenin (Sigma, St. Louis, MO), Smad7 (He et al.,
2002), Ihh (Santa Cruz Biotechnology, Santa Cruz, CA), pSmad2
and pSmad1/5/8 (Cell Signaling Technology, Danvers, MA). IHC or
IF was performed to detect membrane bound b-catenin as previ-
ously described (Han et al., 2005). To detect nuclear b-catenin, IF
was performed by using the same b-catenin antibody, and the sec-
tions were treated with 2 mg/ml BSA and 0.1% Triton at 4C over-
night (Van Mater et al., 2003), conditions that partially destroy mem-
brane-associated epitopes but increase permeability to the nucleus.
RNA Extraction and Analyses
Total RNA was isolated from skin samples with RNAzol B (Tel-Test,
Austin, TX), and quantitative (q)RT-PCR was performed by using
Taqman Assays-on-Demand probes (Applied Biosystems, Foster
City, CA) as previously described (Lu et al., 2004). Results from 3–5
samples of each genotype are shown.
Western Analysis
Protein extraction was performed as previously described (He et al.,
2002). The primary antibodies used included Smad7 (He et al., 2002),
E-cadherin and b-catenin (BD Biosciences, San Jose, CA), Flag
(Sigma), and K14 (Fitzgerald). Gray-scale images were obtained
and quantified with Odyssey v.1.2 software (LI-COR Biosciences,
Lincoln, NE).
Epidermal Keratinocyte and Hair Follicle Cell Culture
Primary epidermal keratinocytes were isolated from neonatal mouse
skin with different genotypes as previously described (Wang et al.,
1997). The cells were cultured in defined keratinocyte serum-free me-
dium (DK-SFM) (Invitrogen) to maintain keratinocyte proliferation.When cells reached nearly 80% confluence, they were treated with
RU486 at a final concentration of 1027M to induce transgene expres-
sion. The cells were harvested 12 hr after RU486 treatment for protein
extraction. Isolation and culture of murine hair follicle cells were per-
formed by following an established protocol with minor modifica-
tions (Rogers et al., 1987). Briefly, neonatal mouse dermis separated
from the epidermis was digested with 0.35% type I collagenase
(Worthington Biochemical, Lakewood, NJ) at 37C for 30 min, filtered
through a cell strainer (BD Biosciences, San Jose, CA), and then
centrifuged at 800 rpm for 5 min. The pellet was resuspended in
1.25 mM Ca2+ EMEM (Cambrex, Walkersville, MD) and then centri-
fuged at 300 rpm for 5 min. Subsequently, the pellet was resus-
pended in 8 ml 1.25 mM Ca2+ EMEM/9% Ficoll (1:1) and overlaid on
5 ml 9% Ficoll for centrifugation at 400 rpm. The precipitated hair
follicles were then washed in 1.25 mM Ca2+ EMEM three times and
plated in 0.05 mM Ca2+ EMEM on type I collagen-coated plates.
The medium was then replaced with 1.25 mM Ca2+ EMEM 24 hr later.
b-Gal Staining
b-gal staining for whole mount, tissue sections, and cells was per-
formed with a b-gal staining kit (Invitrogen, Calsbad, CA), by follow-
ing the manufacturer’s instructions.
Immunoprecipitation
Primary keratinocytes were cultured as described above. When cells
reached subconfluency, RU486 was added at a final concentration of
1027 M to induce Smad7 overexpression. A total of 12 hr later, the
cells were treated with or without MG132 at a final concentration of
20 mM for 4 hr prior to harvesting. Subsequently, the cells were lysed
in 13 CST cell lysis buffer (Cell Signaling Technology) containing
freshly added protease inhibitors that included AEBSF, aprotinin,
bestatin, E-64, leupeptin, and pepstatin A (Sigma). For immunopre-
cipitation, 2 mg of a b-catenin antibody or a Flag antibody was added
to 500mg whole-cell lysate, and 2 mg mouse IgG (Santa Cruz) was used
as a negative control. Protein precipitation and subsequent Western
blotting were carried out as previously described (Lin et al., 2000).
Assay of Ubiquitination and Degradation
of Exogenous b-Catenin
HEK293 T cells were transfected with expression plasmids for His-
tagged b-catenin, Flag-Smurf2, Flag-Smad7, and HA-ubiquitin, as
specified in Figure 5D. A total of 48 hr after transfection, cells were
treated with MG132 at a final concentration of 20 mM for 4 hr prior
to harvesting. His-tagged b-catenin was immobilized on Ni-NTA
beads (Qiagen, Valencia, CA) and then eluted in elution buffer (Lin
et al., 2000). Eluted proteins were subjected to Western blotting
analysis with anti-HA antibody (Roche Diagnostics, Indianapolis,
IN) to detect the b-catenin-ubiquitin conjugation. For the degrada-
tion assay, HEK293 T cells were transfected with expression plas-
mids for His-tagged b-catenin, Flag-Smurf2, and Flag-Smad7. A to-
tal of 48 hr after transfection, protein was extracted from transfected
cells and subjected to Western blotting. The His-b-catenin level was
detected with an anti-His antibody (Santa Cruz), and Smurf2 and
Smad7 levels were detected with an anti-Flag antibody.
Smad7 Knockdown
Smad7 siRNA oligonucleotides were designed to recognize mouse
Smad7 (sense: 50-GAGGCTGTGTTGCTGTGAA-30, antisense: 50-
TTCACAGCAACACAGCCTC-30) and were synthesized (Ambion,
Austin, TX). The annealed double-strand Smad7 siRNA was then
transfected to cultured keratinocytes and hair follicle cells at a final
concentration of 50 nM by using FuGENE 6 (Roche Diagnostics,
Alameda, CA), following the manufacturer’s instructions. Mock
transfections were used as negative controls. The cells were har-
vested 72 hr posttransfection for further analyses.
Supplemental Data
Supplemental data include four figures and are available at http://
www.developmentalcell.com/cgi/content/full/11/3/301/DC1/.
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